A multi-group SEIRA model for the spread of COVID-19 among heterogeneous populations
arXiv:2004.13452 · doi:10.1016/j.chaos.2020.109925
Abstract
The outbreak and propagation of COVID-19 have posed a considerable challenge to modern society. In particular, the different restrictive actions taken by governments to prevent the spread of the virus have changed the way humans interact and conceive interaction. Due to geographical, behavioral, or economic factors, different sub-groups among a population are more (or less) likely to interact, and thus to spread/acquire the virus. In this work, we present a general multi-group SEIRA model for representing the spread of COVID-19 among a heterogeneous population and test it in a numerical case of study. By highlighting its applicability and the ease with which its general formulation can be adapted to particular studies, we expect our model to lead us to a better understanding of the evolution of this pandemic and to better public-health policies to control it.
References in corpus (5)
- Analysis and forecast of COVID-19 spreading in China, Italy and France
- Epidemic analysis of COVID-19 in China by dynamical modeling
- Covid-19 spread: Reproduction of data and prediction using a SIR model on Euclidean network
- A simple Stochastic SIR model for COVID 19 Infection Dynamics for Karnataka: Learning from Europe
- Public Health Policy: COVID-19 Epidemic and SEIR Model with Asymptomatic Viral Carriers
Cited by in corpus (6)
- A New Compartmental Epidemiological Model for COVID-19 with a Case Study of Portugal
- Statistically-based methodology for revealing real contagion trends and correcting delay-induced errors in the assessment of COVID-19 pandemic
- Blockchain for Multi-Robot Collaboration to Combat COVID-19 and Future Pandemics
- On the heterogeneous spread of COVID-19 in Chile
- Modeling the Impact of Social Distancing and Targeted Vaccination on the Spread of COVID-19 through a Real City-Scale Contact Network
- Model-based assessment of sampling protocols for infectious disease genomic surveillance